Bg pattern

XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Xerava 100 mg powder for concentrate for solution for infusion

eravacycline

Read all of this leaflet carefully before you start receiving this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Xerava and what is it used for
  2. What you need to know before you receive Xerava
  3. How Xerava will be administered
  4. Possible side effects
  5. Storage of Xerava
  6. Contents of the pack and other information

1. What is Xerava and what is it used for

What is Xerava

Xerava is an antibiotic that contains the active substance eravacycline. It belongs to a group of antibiotics called "tetracyclines" that work by stopping the growth of certain infectious bacteria.

What Xerava is used for

Xerava is used to treat adults who have a complicated infection in the abdomen.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you receive Xerava

You must not receive Xerava

  • if you are allergic to eravacycline or any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic to any antibiotic of the tetracycline group (e.g. minocycline and doxycycline), as you may also be allergic to eravacycline.

Warnings and precautions

Talk to your doctor or nurse before you start receiving Xerava if you are concerned about any of the following:

Anaphylactic reactions

Anaphylactic reactions (allergic reactions) have been reported with other antibiotics of the tetracycline group. These reactions can occur suddenly and can be life-threatening. Seek urgent medical attentionif you suspect you are having an anaphylactic reaction during treatment with Xerava. The symptoms to watch out for are skin rash, swelling of the face, feeling dizzy or faint, chest tightness, difficulty breathing, rapid heartbeat, or loss of consciousness (see also section 4).

Diarrhea

Talk to your doctor or nurse if you have diarrhea before receiving Xerava. If you get diarrhea during or after treatment, tell your doctor immediately. Do not take any medicine to treat diarrhea without talking to your doctor first (see also section 4).

Infusion site reactions

Xerava is given by infusion (drip) directly into a vein. Tell your doctor or nurseif you notice any of the following effects at the infusion site during or after treatment: skin redness, skin rash, inflammation, and pain or tenderness.

New infection

Although Xerava fights certain bacteria, other bacteria and fungi can still grow. This is called "overgrowth" or "superinfection". Your doctor will monitor you closely for any new infection or will stop treatment with Xerava and give you another treatment if necessary.

Pancreatitis

Severe abdominal and back pain with fever may be a sign of pancreas inflammation. Tell your doctor or nurse if you notice any of these side effects during treatment with Xerava.

Liver problems

Tell your doctor if you have liver problems or are overweight, especially if you are also taking itraconazole (a medicine used to treat fungal infections), ritonavir (a medicine used to treat viral infections), or clarithromycin (an antibiotic), as your doctor will monitor you for possible side effects.

Children and adolescents

This medicine must not be used in children and adolescents under 18 years of age, as it has not been studied sufficiently in these populations. Xerava must not be used in children under 8 years of age, as it may affect teeth permanently with a change in color.

Other medicines and Xerava

Tell your doctor or nurse if you are taking, have recently taken, or might take any other medicines, such as rifampicin and clarithromycin (antibiotics), phenobarbital, carbamazepine, and phenytoin (used to treat epilepsy), St. John's Wort (a herbal medicine used to treat depression and anxiety), itraconazole (a medicine used to treat fungal infections), ritonavir, atazanavir, lopinavir, and saquinavir (medicines used to treat viral infections), and cyclosporin (a medicine used to suppress the immune system).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before receiving this medicine. Xerava is not recommended during pregnancy, as it may:

  • permanently stain the fetus's teeth;
  • delay the natural formation of the fetus's bones.

It is not known if Xerava passes into breast milk. Long-term use of other similar antibiotics by breastfeeding mothers may permanently stain the child's teeth. Ask your doctor for advice before breastfeeding your child.

Driving and using machines

Xerava may affect your ability to drive or use machines. Do not drive or use machines if you feel dizzy, drowsy, or unsteady after receiving this medicine.

3. How Xerava will be administered

Your doctor or nurse will administer Xerava to you.

The recommended dose for adults depends on body weight and is 1 mg/kg every 12 hours. Your doctor may increase the dose (1.5 mg/kg every 12 hours) if you are taking other medicines such as rifampicin, phenobarbital, carbamazepine, phenytoin, or St. John's Wort.

It will be administered by infusion directly into a vein (intravenously) over approximately 1 hour.

A treatment cycle usually lasts from 4 to 14 days. Your doctor will decide how long you should receive treatment.

If you receive more Xerava than you should

A doctor or nurse will administer Xerava to you in a hospital. Therefore, it is unlikely that you will receive too much. Tell your doctor or nurse immediately if you are concerned that you may have received too much Xerava.

If you miss a dose of Xerava

A doctor or nurse will administer Xerava to you in a hospital. Therefore, it is unlikely that you will miss a dose. Tell your doctor or nurse immediately if you are concerned that you may have missed a dose.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Seek urgent medical attentionif you suspect you are having an anaphylactic reaction or experience any of the following symptoms during treatment with Xerava:

  • skin rash
  • swelling of the face
  • feeling dizzy or faint
  • chest tightness
  • difficulty breathing
  • rapid heartbeat
  • loss of consciousness

Tell your doctor or nurse immediatelyif you experience diarrhea during or after treatment. Do not take any medicine to treat diarrhea without talking to your doctor first.

Other side effects may be:

Common(may affect up to 1 in 10 people):

  • nausea
  • vomiting
  • inflammation and pain caused by blood clots at the injection site (thrombophlebitis)
  • inflammation of a vein that causes pain and swelling (phlebitis)
  • redness or swelling at the injection site
  • low levels of fibrinogen in the blood (a protein involved in blood clotting)
  • blood test results that indicate a decrease in blood clotting ability

Uncommon(may affect up to 1 in 100 people):

  • diarrhea
  • allergic reaction
  • inflammation of the pancreas, which causes severe abdominal or back pain (pancreatitis)
  • skin rash
  • dizziness
  • headache
  • increased sweating
  • abnormal liver test results in blood tests

Tell your doctor or nurse if you experience any of these side effects.

Other tetracycline antibiotics

Other side effects have been reported with other tetracyclines, such as minocycline and doxycycline. These include sensitivity to light, headache, vision problems, or abnormal blood test results. Tell your doctor or nurse if you notice any of these side effects during treatment with Xerava.

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Xerava

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the vial after "EXP" and on the carton after "CAD". The expiry date is the last day of the month shown.

Store in a refrigerator (2°C - 8°C). Keep the vial in the outer carton to protect it from light.

Once the powder has been reconstituted and diluted and is ready for use, it must be administered immediately. Otherwise, it can be stored at room temperature and used within 12 hours.

Xerava reconstituted must be a clear solution with a color between light yellow and orange. The solution must not be used if it appears to contain solid particles or is cloudy.

6. Container Content and Additional Information

Xerava Composition

The active ingredient is eravacycline. Each vial contains 100 mg of eravacycline.

The other components are mannitol (E421), hydrochloric acid (for pH adjustment), and sodium hydroxide (for pH adjustment).

Product Appearance and Container Content

Xerava is a compacted powder with a color ranging from light yellow to dark yellow in a 10 ml glass vial. The powder for concentrate for solution for infusion (powder for concentrate) will be reconstituted in the vial with 5 ml of water or with 5 ml of a 9 mg/ml (0.9%) sodium chloride solution for injectable preparations. The reconstituted solution will be extracted from the vial and added to an infusion bag of injectable solution of 9 mg/ml (0.9%) sodium chloride in the hospital.

Xerava is available in containers that contain 1 vial, 10 vials, or in multiple containers that contain 12 boxes, each with 1 vial.

Only some package sizes may be marketed.

Marketing Authorization Holder

PAION Pharma GmbH

Heussstraße 25

52078 Aachen

Germany

Manufacturer

PAION Pharma GmbH

Heussstraße 25

52078 Aachen

Germany

PAION Deutschland GmbH

Heussstraße 25

52078 Aachen

Germany

You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:

België/Belgique/Belgien

Viatris

Tel: + 32 (0)2 658 61 00

Lietuva

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Text in Bulgarian and German with contact information of PAION Deutschland GmbH and phone number

Luxembourg/Luxemburg

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Ceská republika

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Magyarország

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Danmark

PAION Deutschland GmbH

Tlf: + 49 800 4453 4453

Malta

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Deutschland

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Nederland

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Eesti

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Norge

PAION Deutschland GmbH

Tlf: + 49 800 4453 4453

Ελλάδα

Viatris Hellas Ltd

Τηλ: +30 210 0100002

Österreich

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

España

Viatris Pharmaceuticals, S.L.

Tel: + 34 900 102 712

Polska

Viatris Healthcare Sp. z o.o.

Tel: + 48 22 546 64 00

France

Viatris Santé

Tél: +33 4 37 25 75 00

Portugal

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Hrvatska

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

România

BGP Products SRL

Tel: +40 372 579 000

Ireland

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Slovenija

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Ísland

PAION Deutschland GmbH

Sími: + 49 800 4453 4453

Slovenská republika

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Italia

Viatris Italia S.r.l.

Tel: + 39 02 612 46921

Suomi/Finland

PAION Deutschland GmbH

Puh/Tel: + 49 800 4453 4453

Κύπρος

PAION Deutschland GmbH

Τηλ: + 49 800 4453 4453

Sverige

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Latvija

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

United Kingdom (Northern Ireland)

PAION Deutschland GmbH

Tel: + 49 800 4453 4453

Date of Last Revision of this Prospectus:

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

--------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Important: Before prescribing this medicinal product, consult the Summary of Product Characteristics or Package Leaflet.

Xerava must be reconstituted with water for injectable preparations or with a 9 mg/ml (0.9%) sodium chloride solution for injectable preparations and then diluted with a 9 mg/ml (0.9%) sodium chloride injectable solution.

Xerava must not be mixed with other medicinal products. If the same intravenous line is used for the sequential infusion of different medicinal products, the line must be flushed before and after infusion with a 9 mg/ml (0.9%) sodium chloride injectable solution.

The dose must be calculated based on the patient's weight: 1 mg/kg body weight.

Reconstitution Instructions

Aseptic technique must be used to prepare the infusion solution. Each vial must be reconstituted with 5 ml of water for injectable preparations or with 5 ml of a 9 mg/ml (0.9%) sodium chloride solution for injectable preparations and gently rotated until the powder is completely dissolved. Avoid agitation or rapid movement, as this may cause foam formation.

Reconstituted Xerava must be a clear solution with a color ranging from light yellow to orange. The solution must not be used if it contains solid particles or is turbid.

Preparation of the Infusion Solution

For administration, the reconstituted solution must be further diluted with a 9 mg/ml (0.9%) sodium chloride injectable solution. The calculated volume of the reconstituted solution must be added to the infusion bag to achieve a target concentration of 0.3 mg/ml, within a range of 0.2 to 0.6 mg/ml. Table 1 provides examples of calculations.

Gently invert the bag to mix the solution.

Table 1: Examples of Calculations for Weights between 40 kg and 200 kg1

Patient Weight

(kg)

Total Dose (mg)

Number of Vials to Reconstitute

Total Volume to Dilute (ml)

Recommended Infusion Bag Size

40

40

1

2

100 ml

60

60

1

3

250 ml

80

80

1

4

250 ml

100

100

1

5

250 ml

150

150

2

7.5

500 ml

200

200

2

10

500 ml

1 The exact dose must be calculated based on the patient's specific weight.

For patients who weigh between ≥ 40 kg and 49 kg:

Calculate the required volume of reconstituted solution based on the patient's weight and inject it into a 100 ml infusion bag.

For patients who weigh between 50 kg and 100 kg:

Calculate the required volume of reconstituted solution based on the patient's weight and inject it into a 250 ml infusion bag.

For patients who weigh > 100 kg:

Calculate the required volume of reconstituted solution based on the patient's weight and inject it into a 500 ml infusion bag.

Infusion

The infusion solution must be visually inspected for the presence of solid particles before administration.

Reconstituted and diluted solutions that contain visible solid particles or appear turbid must be discarded.

After dilution, Xerava is administered intravenously over approximately 1 hour. The recommended dosage regimen for Xerava is 1 mg/kg every 12 hours for 4 to 14 days.

The reconstituted and diluted solution must be administered only by intravenous infusion. It must not be administered as an intravenous bolus.

For single use; unused solution must be discarded.

Online doctors for XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Томаш Гжеловський

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Даниэль Чики

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (764)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION?
XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION is eravacycline. This information helps identify medicines with the same composition but different brand names.
Who manufactures XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION?
XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION is manufactured by Paion Pharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to XERAVA 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (eravacycline) include DOSIL 100 mg HARD CAPSULES, DOXICICLINA NORMON 100 mg FILM-COATED TABLETS, DOXICLAT 100 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media